CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 53 enrolled
Drug / intervention
clindamycin and benzoyl peroxide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00964366
NCT00964366Phase 4Completed
CompareCT.gov

Two-week Study to Determine and Compare the Tolerance and Irritation Potential of Clindamycin and Benzoyl Peroxide to Dapsone Gel Topical Acne Medications

Stiefel, a GSK Company·interventional·Posted Aug 24, 2009·Updated May 30, 2017

In Brief

A Phase 4 clinical trial evaluating clindamycin and benzoyl peroxide and Dapsone gel for Acne Vulgaris. Completed, enrolled 53 participants across 1 site.

Detailed Summary

This is a randomized, half-face study. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide or dapsone gel and the contra lateral side of the face will remain non-treated to serve as a control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
CollaboratorsGlaxoSmithKline

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 24, 2009
Enrollment StartJul 1, 2009
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.9 years ago

Interventions

clindamycin and benzoyl peroxidedrug

Daily applications, to the randomized side of the face either left or right, of clindamycin and benzoyl peroxide

Dapsone geldrug

Twice-daily applications of dapsone gel